Identification of pre-leukemic hematopoietic stem cells in acute leukemia

[1]  T. Naoe,et al.  Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation , 2014, Leukemia.

[2]  Uku. Innere Medizin.  Clonal evolution in relapsed NPM1 mutated acute myeloid leukemia , 2014 .

[3]  A. Singh,et al.  A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. , 2013, Blood.

[4]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[5]  R. Majeti,et al.  Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia , 2013, International Journal of Hematology.

[6]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[7]  Jian-Bing Fan,et al.  The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment , 2013, Nature Immunology.

[8]  A. Raza,et al.  The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes , 2012, Nature Reviews Cancer.

[9]  Peter J. Campbell,et al.  Evolution of the cancer genome , 2012, Nature Reviews Genetics.

[10]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[11]  O. Abdel-Wahab,et al.  The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.

[12]  I. Weissman,et al.  Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.

[13]  E. Shapiro,et al.  Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability. , 2012, Blood.

[14]  N. Socci,et al.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.

[15]  Ken Chen,et al.  Clonal architecture of secondary acute myeloid leukemia. , 2012, The New England journal of medicine.

[16]  Elisa Laurenti,et al.  Hematopoiesis: a human perspective. , 2012, Cell stem cell.

[17]  Joshua F. McMichael,et al.  Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.

[18]  Sebastian Bauer,et al.  The allele distribution in next-generation sequencing data sets is accurately described as the result of a stochastic branching process , 2011, Nucleic acids research.

[19]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[20]  A. Jankowska,et al.  Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. , 2011, Blood.

[21]  Angelo J. Canty,et al.  Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.

[22]  G. Vince.  A human perspective , 2011 .

[23]  K. Akashi,et al.  Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. , 2011, Cancer cell.

[24]  Igor Jurisica,et al.  Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment , 2011, Science.

[25]  F. Sigaux,et al.  Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse , 2011 .

[26]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[27]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[28]  Li Ding,et al.  Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.

[29]  James R. Downing,et al.  Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells , 2011, Nature.

[30]  K. Anderson,et al.  Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.

[31]  Claire Schwab,et al.  Acute lymphoblastic leukaemia. , 2011, Methods in molecular biology.

[32]  Andrew Menzies,et al.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.

[33]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[34]  J. Dick,et al.  Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development , 2010, Nature Immunology.

[35]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[36]  D. Sgroi,et al.  Preinvasive breast cancer. , 2010, Annual review of pathology.

[37]  J. Salk.  Clonal evolution in cancer , 2010 .

[38]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[39]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[40]  James R. Downing,et al.  Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.

[41]  Hideo Ema,et al.  De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells , 2007, The Journal of experimental medicine.

[42]  I. Wistuba,et al.  Smoking molecular damage in bronchial epithelium , 2002, Oncogene.

[43]  S. Langabeer,et al.  Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. , 2002, Blood.

[44]  J. Tisdale,et al.  Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. , 2000, Blood.

[45]  I. Weissman,et al.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Cleton.  Evolution of Cancer , 1991, British Journal of Cancer.

[47]  C. Bartram,et al.  Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy. , 1991, Blood.

[48]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[49]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[50]  P. Nowell,et al.  Karyotypic evolution in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.

[51]  A. Feinberg,et al.  Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. , 1985, Science.

[52]  M. Minden,et al.  Acute myeloblastic leukemia considered as a clonal hemopathy. , 1979, Blood cells.

[53]  S. Gartler,et al.  Clonal origin of chronic myelocytic leukemia in man. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Burt,et al.  The Human Perspective , 2015, Perspectives in biology and medicine.